About CRA | Expertise | Consultants | Publications | News | Events | Offices | Careers                                                                         
Take a closer look. The European Commission launched a sector inquiry into the pharmaceutical
industry, targeting allegations that generic entry was delayed and innovation had declined. On behalf
of EFPIA, the branded manufacturers' trade association, CRA responded with two reports discussing
competition and innovation in pharmaceutical markets.


CRA International has established a significant presence in Europe and advises clients on a range of economic, strategic, financial and forensic accounting matters. From our offices in London, Amsterdam, Brussels, Frankfurt, London, and Paris, CRA’s experts and business advisors are on hand to support both European and international clients on issues across a wide variety of sectors.